Apply Now

Alchemist Blog

Alchemist Press

Alchemist Blog

Alchemist Press

Influencer Series: Will AI Agents Replace Software Engineers or Make Them More Powerful Than Ever?

International founders often stumble in the U.S. market. Learn what separates successful entrants from failures—and how to build for American customers.

Read post >
Meet the Inaugural Alchemist Chicago Cohort

Alchemist Chicago will support early-stage ventures across quantum, AI, cleantech, robotics, and other deep tech industries, transforming discovery into impact.

Read post >
Influencer Series: Building for the U.S. Market? Here's What Most International Founders Get Wrong

International founders often stumble in the U.S. market. Learn what separates successful entrants from failures—and how to build for American customers.

Read post >
Influencer Series: Why Enterprises Don’t Trust AI in Regulated Industries

AI in regulated industries faces a trust crisis. Explore barriers, solutions, and frameworks to deploy AI responsibly while ensuring compliance and safety.

Read post >
Influencer Series: Why Enterprises Are Still Hesitant to Adopt AI Teammates Despite the Hype

Drawing on research, case studies, and Rishi’s deep venture experience, he shares how misaligned expectations, cultural resistance, and trust deficits slow adoption—and what leaders can do to build trust and integrate AI successfully.

Read post >
Influencer Series: AI Startup Secrets & Must-Know Tips for Founders!

Alchemist partner and coach Gnani Palanikumar shares insider strategies for AI founders: from validating problem hypotheses to scaling products efficiently.

Read post >
Influencer Series: Why One AI Agent Isn’t Enough, & The Case for Specialized, Networked Intelligence

In this episode, Not Diamond co-founder and former VC Jeffrey Akiki joins Alchemist Accelerator CEO Ravi Belani to share why the smartest AI systems don’t depend on just one model or agent.

Read post >
Building Biotech to Last: How Mammoth Biosciences Is Redefining the Future of CRISPR and Platform Innovation

Discover how Mammoth Biosciences is transforming the biotech landscape with a platform approach to CRISPR, combining diagnostics, therapeutics, and ethical leadership.

Read post >